XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 47,959 $ 37,739 $ 98,534 $ 66,168
Acquired in-process research and development 0 0 12,500 0
General and administrative 13,841 11,875 29,243 23,821
Total operating expenses 61,800 49,614 140,277 89,989
Interest income (3,572) (1,154) (7,637) (1,154)
Other income, net (20) (793) (484) (1,147)
Loss before provision for income taxes (58,208) (47,667) (132,156) (87,688)
Provision for income taxes 454 261 443 613
Net loss $ (58,662) $ (47,928) $ (132,599) $ (88,301)
Net loss per common share - basic (in dollars per share) $ (0.45) $ (0.41) $ (1.01) $ (0.76)
Net loss per common share - diluted (in dollars per share) $ (0.45) $ (0.41) $ (1.01) $ (0.76)
Weighted-average common shares outstanding – basic (in shares) 131,155,642 116,572,820 130,872,717 116,630,076
Weighted-average common shares outstanding – diluted (in shares) 131,155,642 116,572,820 130,872,717 116,630,076